Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients

Annals of Surgical Oncology(2024)10.1245/s10434-024-16630-wSource: DataRank Database

Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients is a research paper published in Annals of Surgical Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.35)OA: greenTopics (67)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Zachary Schrank ORCID,Chris B Agala,David W. Ollila ORCID,Kristalyn K. Gallagher ORCID,Dana L. Casey ORCID

Live enrichment

PubMed:39674862 PMC:PMC12424456 OpenAlex:https://openalex.org/W4405392483

Basic Research Laboratory

Grant: K08CA280388

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Grant: P30CA016086

NCI NIH HHS

Grant: R37 CA292075

National Institutes of Health

Grant: 3P30CA016086-42S2

Cancer Center Support Grant

National Institutes of Health

Grant: 1K08CA280388-01

Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer

FWCI

0.35

Citation Percentile

0.6%

Citation Trend

2024

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12424456/pdf/nihms-2093011.pdf

publisherhttps://link.springer.com/content/pdf/10.1245/s10434-024-16630-w.pdf

publisherhttps://link.springer.com/article/10.1245/s10434-024-16630-w/fulltext.html

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12424456/

Fields of Study

Breast Cancer Treatment StudiesBreast Implant and ReconstructionBreast Lesions and CarcinomasMedicine03 medical and health sciences0302 clinical medicineHumansFemaleBreast NeoplasmsAxillaSentinel Lymph Node BiopsyLymph Node ExcisionMiddle AgedSurvival RateNeoplasm StagingNeoadjuvant TherapyAgedPrognosisFollow-Up StudiesAdultLymphatic MetastasisRetrospective StudiesCarcinoma, Ductal, Breast

MeSH Terms

AdultAgedAxillaBreast NeoplasmsFemaleFollow-Up StudiesHumansLymph Node ExcisionLymphatic MetastasisMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesSurvival RateCarcinoma, Ductal, BreastNeoadjuvant TherapySentinel Lymph Node Biopsy

Keywords

MedicineAxillary Lymph Node DissectionBreast cancerSentinel lymph nodeAxillaSurgical oncologySurgeryStage (stratigraphy)CancerInternal medicineAdultSentinel Lymph Node BiopsyCarcinoma, Ductal, BreastBreast NeoplasmsMiddle AgedPrognosisArticleNeoadjuvant TherapySurvival RateLymphatic MetastasisHumansLymph Node ExcisionFemaleNeoplasm StagingAgedFollow-Up StudiesRetrospective Studies

Sustainable Development Goals

SDG 0: Good health and well-being